We support clients from ideation and planning, through all aspects of diligence, and finally through integration and separation.
The Precision Medicine deal market is one of the most active and dynamic in the Life Sciences industry. Our Precision Medicine team provides clients with end-to-end deal support, from deal strategy, target identification and prioritization, commercial, financial and operational diligence, to execution for acquisitions, mergers, and divestitures and post-deal value capture. Our practice has been on the buy- and sell-side for deals in the Precision Medicine ecosystem for both corporate and private entities.
M&A services across the deal cycle for a leading diagnostics client
Download PDFCompetitive positioning for a next generation sequencing device
Download PDFCommercial due diligence in the neurodegenerative disease space
Download PDFIndustry insights and trends, one click away.